Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Seres Therapeutics Inc (NASDAQ: MCRB) was $0.97 for the day, down -5.38% from the previous closing price of $1.02. In other words, the price has decreased by -$5.38 from its previous closing price. On the day, 3.43 million shares were traded. MCRB stock price reached its highest trading level at $1.07 during the session, while it also had its lowest trading level at $0.96.
Ratios:
Our analysis of MCRB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.25 and its Current Ratio is at 1.68.
On April 21, 2023, JP Morgan started tracking the stock assigning a Neutral rating and target price of $7.
Goldman Downgraded its Neutral to Sell on July 23, 2021, whereas the target price for the stock was revised from $24 to $7.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 16 ’24 when Shaff Eric D. sold 11,549 shares for $1.08 per share. The transaction valued at 12,473 led to the insider holds 135,321 shares of the business.
Ege David S. sold 5,010 shares of MCRB for $5,411 on Feb 16 ’24. The insider now owns 73,856 shares after completing the transaction at $1.08 per share. On Feb 16 ’24, another insider, von Moltke Lisa, who serves as the insider of the company, sold 4,400 shares for $1.08 each. As a result, the insider received 4,752 and left with 16,988 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MCRB now has a Market Capitalization of 146162464 and an Enterprise Value of 249161232. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.15. Its current Enterprise Value per Revenue stands at 1.964 whereas that against EBITDA is -3.529.
Stock Price History:
Over the past 52 weeks, MCRB has reached a high of $6.26, while it has fallen to a 52-week low of $0.54. The 50-Day Moving Average of the stock is 15.73%, while the 200-Day Moving Average is calculated to be -42.23%.
Shares Statistics:
MCRB traded an average of 4.95M shares per day over the past three months and 7811720 shares per day over the past ten days. A total of 135.04M shares are outstanding, with a floating share count of 119.79M. Insiders hold about 20.91% of the company’s shares, while institutions hold 43.33% stake in the company. Shares short for MCRB as of 1714435200 were 21462357 with a Short Ratio of 4.34, compared to 1711584000 on 18803257. Therefore, it implies a Short% of Shares Outstanding of 21462357 and a Short% of Float of 19.91.
